cd45ra antibody, anti-human, reafinity (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
93
Structured Review
Miltenyi Biotec
cd45ra antibody, anti-human, reafinity
Cd45ra Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 83 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45ra/CD45RA+Antibody%2C+anti-human%2C+REAfinity/custom%40130-122-292%4042502392
Average 93 stars, based on 83 article reviews
Cd45ra Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 83 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45ra/CD45RA+Antibody%2C+anti-human%2C+REAfinity/custom%40130-122-292%4042502392
Average 93 stars, based on 83 article reviews
cd45ra antibody, anti-human, reafinity - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Recombinase Polymerase Amplification:Article Title: Article Snippet: .. Research Resource Identifiers (RRIDs) were obtained from The Antibody Registry (antibodyregistry.org): HLA-DR (Cat# 564040, BD Biosciences RRID:AB_2738558, Clone G46-6, 1:250) CD8 (Cat# 612942, Becton Dickinson, RRID:AB_2870223, Clone RPA-T8, 1:1000) CD27 (Cat# 741833, Becton Dickinson, RRID:AB_2871168, Clone M-T271, 1:500) CD4 (Cat# 612887, Becton Dickinson, RRID:AB_2870176, Clone SK3, 1:250) CD45RA (Cat# 566114, Becton Dickinson, RRID:AB_2739516, Clone HI100, 1:1000) CD57 (Cat# 393304, Biolegend, RRID:AB_2728425, Clone QA17A04, 1:1000) CD62L (Cat# 563808, Becton Dickinson, RRID:AB_2738433, Clone DREG-56, 1:500) TIM3 (Cat# 565566, Becton Dickinson, RRID:AB_2744370, Clone 7D3, 1:1000) CD25 (Cat# 563701, Becton Dickinson, RRID:AB_2744338, Clone M-A251, 1:500) CFSE (Cat# C34554, ThermoFisher, 1:1000) TIGIT (Cat# 46-9500-42, Invitrogen, RRID:AB_10853679, Clone MBSA43, 1:1000) CCR7 (Cat# 353236, Biolegend, RRID:AB_2563640, Clone G043H7, 1:1000) PD-1 (Cat# 561272, Becton Dickinson, RRID:AB_10611585, Clone N/A, 1:1000) LAG3 (Cat# 369304, Biolegend, RRID:AB_2566480, Clone 11C3C65, 1:500) FVS780 (Cat# 565388, Becton Dickinson, 1:1000) Jovi1 (Cat# ANC-101-030, Ancell, lone JOVI-1, 1:1000) Humanized Jovi 1 and variants were in house generated Anti-idiotype for Jovi-1 was in house generated aCD3 (Cat# 317334, Biolegend, RRID:AB_2561452, Clone OKT3, 1:1000) Streptavidin (Cat# 405243, Biolegend, 1:1000) Anti-CD34 (Cat# 343607, Biolegend, RRID:AB_2074356, Clone 561, 1:200) anti TCR alpha/beta Monoclonal Antibody (WT31) PE conjugated (Cat# 12-9955-42, eBioscience, RRID:AB_10596819, Clone WT31, 1:1000) Goat anti-Human IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa FluorTM 647 (Cat# A-21445, Invitrogen, RRID:AB_2535862, Clone N/A, 1:1000) Goat anti-Mouse IgG2a Cross-Adsorbed Secondary Antibody, Alexa FluorTM 488 (Cat# A-21131, Invitrogen, RRID:AB_2535771, Clone N/A, 1:1000) HuAnti-CD34 (Cat# FAB7227A, R&D System, RRID:AB_10972777, Clone QBend10, 1:200) Anti CD3 (Milteny, Cat# 130-113-142, RRID:AB_2725970, Clone REA613, 1:500) Anti Article Title: Article Snippet: If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. ary April 2023 Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Clinical data Dual use research of concern Plants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used Antibodies for in vitro treatments: vedolizumab (Takeda), natalizumab (Biogen), ETZ-s (BioXcell [#BE0062]), IgG from rat serum (Merck [I4131]), CD103 (Biolegend [350202]), Purified Mouse IgG1, κ Isotype Ctrl Antibody [400102]). .. Flow cytometry: CD3 (BUV395, SK7, BD Biosciences [564001] / APC, HIT3a, Biolegend [300312] / FITC, OKT3, Biolegend [317306], PE/Cy7, SK7, Biolegend [344816]), CD4 (BUV496, SK3, BD Biosciences [612937] / VioBlue /APC-Vio770, VIT4, Miltenyi Biotec [130-113-781/130-113-211]), CD8a (PerCP/Cy5.5 / FITC, RPA-T8, Biolegend [301032/301006]), CD25 (FITC, M-A251, Biolegend [356106]), Generated:Article Title: Article Snippet: .. Research Resource Identifiers (RRIDs) were obtained from The Antibody Registry (antibodyregistry.org): HLA-DR (Cat# 564040, BD Biosciences RRID:AB_2738558, Clone G46-6, 1:250) CD8 (Cat# 612942, Becton Dickinson, RRID:AB_2870223, Clone RPA-T8, 1:1000) CD27 (Cat# 741833, Becton Dickinson, RRID:AB_2871168, Clone M-T271, 1:500) CD4 (Cat# 612887, Becton Dickinson, RRID:AB_2870176, Clone SK3, 1:250) CD45RA (Cat# 566114, Becton Dickinson, RRID:AB_2739516, Clone HI100, 1:1000) CD57 (Cat# 393304, Biolegend, RRID:AB_2728425, Clone QA17A04, 1:1000) CD62L (Cat# 563808, Becton Dickinson, RRID:AB_2738433, Clone DREG-56, 1:500) TIM3 (Cat# 565566, Becton Dickinson, RRID:AB_2744370, Clone 7D3, 1:1000) CD25 (Cat# 563701, Becton Dickinson, RRID:AB_2744338, Clone M-A251, 1:500) CFSE (Cat# C34554, ThermoFisher, 1:1000) TIGIT (Cat# 46-9500-42, Invitrogen, RRID:AB_10853679, Clone MBSA43, 1:1000) CCR7 (Cat# 353236, Biolegend, RRID:AB_2563640, Clone G043H7, 1:1000) PD-1 (Cat# 561272, Becton Dickinson, RRID:AB_10611585, Clone N/A, 1:1000) LAG3 (Cat# 369304, Biolegend, RRID:AB_2566480, Clone 11C3C65, 1:500) FVS780 (Cat# 565388, Becton Dickinson, 1:1000) Jovi1 (Cat# ANC-101-030, Ancell, lone JOVI-1, 1:1000) Humanized Jovi 1 and variants were in house generated Anti-idiotype for Jovi-1 was in house generated aCD3 (Cat# 317334, Biolegend, RRID:AB_2561452, Clone OKT3, 1:1000) Streptavidin (Cat# 405243, Biolegend, 1:1000) Anti-CD34 (Cat# 343607, Biolegend, RRID:AB_2074356, Clone 561, 1:200) anti TCR alpha/beta Monoclonal Antibody (WT31) PE conjugated (Cat# 12-9955-42, eBioscience, RRID:AB_10596819, Clone WT31, 1:1000) Goat anti-Human IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa FluorTM 647 (Cat# A-21445, Invitrogen, RRID:AB_2535862, Clone N/A, 1:1000) Goat anti-Mouse IgG2a Cross-Adsorbed Secondary Antibody, Alexa FluorTM 488 (Cat# A-21131, Invitrogen, RRID:AB_2535771, Clone N/A, 1:1000) HuAnti-CD34 (Cat# FAB7227A, R&D System, RRID:AB_10972777, Clone QBend10, 1:200) Anti CD3 (Milteny, Cat# 130-113-142, RRID:AB_2725970, Clone REA613, 1:500) Anti Biomarker Discovery:Article Title: Article Snippet: .. Research Resource Identifiers (RRIDs) were obtained from The Antibody Registry (antibodyregistry.org): HLA-DR (Cat# 564040, BD Biosciences RRID:AB_2738558, Clone G46-6, 1:250) CD8 (Cat# 612942, Becton Dickinson, RRID:AB_2870223, Clone RPA-T8, 1:1000) CD27 (Cat# 741833, Becton Dickinson, RRID:AB_2871168, Clone M-T271, 1:500) CD4 (Cat# 612887, Becton Dickinson, RRID:AB_2870176, Clone SK3, 1:250) CD45RA (Cat# 566114, Becton Dickinson, RRID:AB_2739516, Clone HI100, 1:1000) CD57 (Cat# 393304, Biolegend, RRID:AB_2728425, Clone QA17A04, 1:1000) CD62L (Cat# 563808, Becton Dickinson, RRID:AB_2738433, Clone DREG-56, 1:500) TIM3 (Cat# 565566, Becton Dickinson, RRID:AB_2744370, Clone 7D3, 1:1000) CD25 (Cat# 563701, Becton Dickinson, RRID:AB_2744338, Clone M-A251, 1:500) CFSE (Cat# C34554, ThermoFisher, 1:1000) TIGIT (Cat# 46-9500-42, Invitrogen, RRID:AB_10853679, Clone MBSA43, 1:1000) CCR7 (Cat# 353236, Biolegend, RRID:AB_2563640, Clone G043H7, 1:1000) PD-1 (Cat# 561272, Becton Dickinson, RRID:AB_10611585, Clone N/A, 1:1000) LAG3 (Cat# 369304, Biolegend, RRID:AB_2566480, Clone 11C3C65, 1:500) FVS780 (Cat# 565388, Becton Dickinson, 1:1000) Jovi1 (Cat# ANC-101-030, Ancell, lone JOVI-1, 1:1000) Humanized Jovi 1 and variants were in house generated Anti-idiotype for Jovi-1 was in house generated aCD3 (Cat# 317334, Biolegend, RRID:AB_2561452, Clone OKT3, 1:1000) Streptavidin (Cat# 405243, Biolegend, 1:1000) Anti-CD34 (Cat# 343607, Biolegend, RRID:AB_2074356, Clone 561, 1:200) anti TCR alpha/beta Monoclonal Antibody (WT31) PE conjugated (Cat# 12-9955-42, eBioscience, RRID:AB_10596819, Clone WT31, 1:1000) Goat anti-Human IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa FluorTM 647 (Cat# A-21445, Invitrogen, RRID:AB_2535862, Clone N/A, 1:1000) Goat anti-Mouse IgG2a Cross-Adsorbed Secondary Antibody, Alexa FluorTM 488 (Cat# A-21131, Invitrogen, RRID:AB_2535771, Clone N/A, 1:1000) HuAnti-CD34 (Cat# FAB7227A, R&D System, RRID:AB_10972777, Clone QBend10, 1:200) Anti CD3 (Milteny, Cat# 130-113-142, RRID:AB_2725970, Clone REA613, 1:500) Anti Article Title: Article Snippet: If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. ary April 2023 Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Clinical data Dual use research of concern Plants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used Antibodies for in vitro treatments: vedolizumab (Takeda), natalizumab (Biogen), ETZ-s (BioXcell [#BE0062]), IgG from rat serum (Merck [I4131]), CD103 (Biolegend [350202]), Purified Mouse IgG1, κ Isotype Ctrl Antibody [400102]). .. Flow cytometry: CD3 (BUV395, SK7, BD Biosciences [564001] / APC, HIT3a, Biolegend [300312] / FITC, OKT3, Biolegend [317306], PE/Cy7, SK7, Biolegend [344816]), CD4 (BUV496, SK3, BD Biosciences [612937] / VioBlue /APC-Vio770, VIT4, Miltenyi Biotec [130-113-781/130-113-211]), CD8a (PerCP/Cy5.5 / FITC, RPA-T8, Biolegend [301032/301006]), CD25 (FITC, M-A251, Biolegend [356106]), Marker:Article Title: Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricide Article Snippet: .. T-cell subtypes were analysed with Article Title: Method for improving production of car T cells Article Snippet: .. Marker Surface Detection The proportion of T-cells expressing the CAR at their surface was then quantified using the following antibodies: CD3: Clone BW264/56, Vioblue (Miltenyi #130-094-363), TCRαβ: Clone REA652, PE (Miltenyi #130-109-920), CD4: Clone VIT4, PEVio770 (Miltenyi #130-096-552), CD8: Clone SK1, BV510 (Biolegend #344732), CD62L: Clone 145/15, APC (Miltenyi #130-113-617), Expressing:Article Title: Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricide Article Snippet: .. T-cell subtypes were analysed with Article Title: Method for improving production of car T cells Article Snippet: .. Marker Surface Detection The proportion of T-cells expressing the CAR at their surface was then quantified using the following antibodies: CD3: Clone BW264/56, Vioblue (Miltenyi #130-094-363), TCRαβ: Clone REA652, PE (Miltenyi #130-109-920), CD4: Clone VIT4, PEVio770 (Miltenyi #130-096-552), CD8: Clone SK1, BV510 (Biolegend #344732), CD62L: Clone 145/15, APC (Miltenyi #130-113-617), Staining:Article Title: Frequency of synaptic antigen-specific CD4 + T cells in dementia is age-dependent but not correlated with cognitive impairment. Article Snippet: .. Cell staining and Fluorescence activated cell scanning (FACS) Extracellular markers were stained with antibodies targeting CD14 (FITC, Miltenyi, TÜK4, 130–113–146, 1:50), CD20 (FITC, Miltenyi, LT20, 130–113–373, 1:50), CD4 (VIT4, VioBlue, Miltenyi, 130–113–219, 1:50), Fluorescence:Article Title: Frequency of synaptic antigen-specific CD4 + T cells in dementia is age-dependent but not correlated with cognitive impairment. Article Snippet: .. Cell staining and Fluorescence activated cell scanning (FACS) Extracellular markers were stained with antibodies targeting CD14 (FITC, Miltenyi, TÜK4, 130–113–146, 1:50), CD20 (FITC, Miltenyi, LT20, 130–113–373, 1:50), CD4 (VIT4, VioBlue, Miltenyi, 130–113–219, 1:50), FACS:Article Title: Frequency of synaptic antigen-specific CD4 + T cells in dementia is age-dependent but not correlated with cognitive impairment. Article Snippet: .. Cell staining and Fluorescence activated cell scanning (FACS) Extracellular markers were stained with antibodies targeting CD14 (FITC, Miltenyi, TÜK4, 130–113–146, 1:50), CD20 (FITC, Miltenyi, LT20, 130–113–373, 1:50), CD4 (VIT4, VioBlue, Miltenyi, 130–113–219, 1:50), Imaging:Article Title: Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma Article Snippet: Fluorochromes were photobleached or released using REAlease technology (Miltenyi) after image acquisition at the end of each staining cycle. .. The following antibodies (all from Miltenyi Biotec) were used: Ki67, CD3, CD4, CD8, CD44, Software:Article Title: Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma Article Snippet: Fluorochromes were photobleached or released using REAlease technology (Miltenyi) after image acquisition at the end of each staining cycle. .. The following antibodies (all from Miltenyi Biotec) were used: Ki67, CD3, CD4, CD8, CD44, Flow Cytometry:Article Title: Article Snippet: If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. ary April 2023 Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Clinical data Dual use research of concern Plants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used Antibodies for in vitro treatments: vedolizumab (Takeda), natalizumab (Biogen), ETZ-s (BioXcell [#BE0062]), IgG from rat serum (Merck [I4131]), CD103 (Biolegend [350202]), Purified Mouse IgG1, κ Isotype Ctrl Antibody [400102]). .. Flow cytometry: CD3 (BUV395, SK7, BD Biosciences [564001] / APC, HIT3a, Biolegend [300312] / FITC, OKT3, Biolegend [317306], PE/Cy7, SK7, Biolegend [344816]), CD4 (BUV496, SK3, BD Biosciences [612937] / VioBlue /APC-Vio770, VIT4, Miltenyi Biotec [130-113-781/130-113-211]), CD8a (PerCP/Cy5.5 / FITC, RPA-T8, Biolegend [301032/301006]), CD25 (FITC, M-A251, Biolegend [356106]), |
